A patient with cellulitis who has completed a 10‑day course of doxycycline but still has persistent redness, warmth, and swelling—what is the next step in management?

Cellulitis Not Responding to Doxycycline: Next Steps

Switch immediately to a β-lactam antibiotic—either cephalexin, amoxicillin, or penicillin—because doxycycline is not first-line therapy for typical non-purulent cellulitis and the persistent symptoms after 10 days indicate treatment failure. 1

Why Doxycycline Failed

• Doxycycline is not recommended for typical cellulitis. The IDSA strongly recommends β-lactam monotherapy (penicillin, cephalexin, or amoxicillin) as first-line treatment because the causative organisms—β-hemolytic Streptococcus and methicillin-sensitive Staphylococcus aureus—are best covered by these agents. 1, 2

• β-lactams achieve cure rates of approximately 96% in typical cellulitis, whereas doxycycline lacks optimal activity against streptococci, the most common pathogen. 1, 3

• MRSA coverage (which doxycycline provides) is unnecessary in typical non-purulent cellulitis unless specific risk factors are present: penetrating trauma, purulent drainage, injection drug use, or concurrent MRSA infection elsewhere. 1

Immediate Management Algorithm

Step 1: Switch Antibiotics

• Start a β-lactam immediately: cephalexin 500 mg four times daily, amoxicillin 500 mg three times daily, or penicillin V 500 mg four times daily. 1, 3

• Duration: 5 days is sufficient if clinical improvement is evident by day 5; extend only if symptoms persist. 1

Step 2: Reassess the Diagnosis

• Consider cellulitis mimickers if the patient fails to improve on appropriate β-lactam therapy within 48–72 hours. Common mimickers include venous stasis dermatitis, contact dermatitis, eczema, and lymphedema—all of which present with redness, warmth, and swelling but are non-infectious. 3, 4

• Re-examine for purulence or abscess formation, which would require incision and drainage in addition to antibiotics. 5

• Evaluate for deeper or necrotizing infection (necrotizing fasciitis, osteomyelitis) if the patient appears systemically ill, has severe pain out of proportion to exam findings, or has crepitus. 6, 7

Step 3: Address Modifiable Risk Factors

• Examine the toe webs carefully for interdigital tinea pedis (athlete's foot), which is the most preventable contributor to cellulitis recurrence and creates portals of bacterial entry. Treat aggressively with topical antifungals. 1

• Assess for lymphedema or chronic edema, the single most important modifiable risk factor for recurrence. Initiate compression therapy and consider formal vascular evaluation if venous insufficiency is present. 1

• Elevate the affected limb to facilitate gravity-driven edema drainage, which improves outcomes. 1

• Apply daily emollients to maintain skin barrier integrity, especially in toe-web spaces, to prevent fissuring. 1

When to Add MRSA Coverage

• Do not add MRSA-active agents (vancomycin, doxycycline, trimethoprim-sulfamethoxazole) unless the patient has specific risk factors: penetrating trauma, purulent drainage, injection drug use, or documented MRSA infection elsewhere. 1

• Rising community MRSA rates do not justify routine coverage for non-purulent cellulitis; β-lactams remain highly effective. 3, 6

Red Flags Requiring Urgent Reassessment

• Failure to improve within 48–72 hours on β-lactam therapy should prompt consideration of resistant organisms, alternative diagnoses (mimickers), or underlying complicating conditions such as immunosuppression, chronic liver disease, or chronic kidney disease. 2, 8

• Systemic signs of severe infection—fever, hypotension, altered mental status, or elevated early warning score (EWS ≥3)—predict worse outcomes including ICU admission and prolonged hospitalization. 7

• Rapid progression, severe pain, or skin necrosis suggests necrotizing fasciitis and requires immediate surgical consultation. 6

Common Pitfalls to Avoid

• Do not continue doxycycline or add MRSA coverage empirically; this perpetuates inappropriate antibiotic use and contributes to resistance. 1, 6

• Do not overlook non-infectious mimickers, which account for a substantial proportion of misdiagnosed "cellulitis" cases and lead to unnecessary antibiotic exposure and hospital admissions. 3, 4

• Do not neglect toe-web examination; untreated tinea pedis is a major preventable risk factor that will lead to recurrent episodes. 1